Retatrutide

A triple-hormone peptide (GIP, GLP-1 and glucagon receptors) studied for weight and metabolic health in large human trials.

Randomised trial2 studies2 min readUpdated 2 Oct 2026

What are the key numbers?

−25.0%body weight at 80 weeksPhase 3 TRIUMPH-1, 2,339 adults with obesity, 12 mg dose; placebo −3.9%Randomised trialPubMed
−24.2%body weight at 48 weeksPhase 2 trial, 338 adults with obesity, highest dose (12 mg); placebo −2.1%Randomised trialPubMed
83%lost 15% or more of body weight by week 48Phase 2 trial, 12 mg group; 2% of the placebo groupRandomised trialPubMed

How does it work?

Retatrutide activates three hormone receptors at once: GLP-1, GIP and glucagon. GLP-1 and GIP signal fullness and help regulate blood sugar, while glucagon signalling raises the energy the body uses. In trials this showed as lower appetite and steady weight loss.

What does the research say?

Published studies, strongest evidence first.

What does the community report?

Community anecdotes, not scientific evidence.

  • Some users report substantial, steady weight loss over several months.From r/Peptides · 1 thread

  • Several people describe quieter food noise and less interest in fast food.From r/Peptides · 1 thread

  • Some users report losing interest in alcohol and other habitual cravings.

Community reports are not evidence. Side effects recorded in the studies are in the research summary above.

  • Substantial weight loss3 threads
  • Reduced appetite and food noise2 threads

Discussed on Reddit

What should you know?

  • There are randomised trials in people, the strongest kind of evidence.
  • For research and education, not medical advice. Talk to a health professional before using any peptide.

Frequently asked questions

What is Retatrutide?

A triple-hormone peptide (GIP, GLP-1 and glucagon receptors) studied for weight and metabolic health in large human trials.

How strong is the evidence for Retatrutide?

There are randomised trials in people, the strongest kind of evidence. This summary covers 2 published studies, each labelled by study type.

Is Retatrutide registered with BPOM?

No. Retatrutide from Continue is a research-grade compound, not a medicine, and is not registered with BPOM.

Where can I buy Retatrutide with a COA in Indonesia?

Continue sells research-grade Retatrutide with a COA for every batch, shipped cold across Indonesia.

Retatrutide
Available at ContinueRetatrutideFrom Rp 3.200.000 Rp 4.000.000
View product

Tested in an Indonesian research institution.

Every batch we ship has undergone testing at a university laboratory or an independent research institution in Indonesia. A Certificate of Analysis is available for every order.

Free Consultation

Certificate of Analysis

  • Purity
  • Heavy metals
  • Endotoxin

Want to know which lab tested your batch? Ask during your consultation.

Confused About Choosing the Right Product?

Our expert team is ready to help for free.

Tell us your goals and we'll recommend the most suitable protocol.

Free Consultation

Disclaimer: Recommendations are for informational purposes only and do not replace medical consultation.